MACOM CEO sells 15,828 shares under 10b5-1 plan
MACOM Technology Solutions Holdings, Inc. President and CEO Stephen G. Daly reported multiple open-market sales of the company’s common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MACOM Technology Solutions Holdings, Inc. President and CEO Stephen G. Daly reported multiple open-market sales of the company’s common stock. On May 29, 2026, he sold a total of 15,828 shares in 19 separate transactions.
The sales were made under a pre-arranged sales plan adopted on February 27, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Footnotes state the reported per-share prices are weighted averages, with individual trades executed in price ranges from about $357.82 to $391.18 per share.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,500 | $358.44 | $538K |
| Sale | Common Stock | 2,200 | $359.37 | $791K |
| Sale | Common Stock | 400 | $360.49 | $144K |
| Sale | Common Stock | 904 | $362.02 | $327K |
| Sale | Common Stock | 2,429 | $362.94 | $882K |
| Sale | Common Stock | 2,075 | $363.87 | $755K |
| Sale | Common Stock | 2,820 | $364.89 | $1.03M |
| Sale | Common Stock | 300 | $366.46 | $110K |
| Sale | Common Stock | 600 | $367.95 | $221K |
| Sale | Common Stock | 300 | $369.38 | $111K |
| Sale | Common Stock | 300 | $374.09 | $112K |
| Sale | Common Stock | 200 | $375.10 | $75K |
| Sale | Common Stock | 400 | $378.86 | $152K |
| Sale | Common Stock | 100 | $380.98 | $38K |
| Sale | Common Stock | 100 | $382.60 | $38K |
| Sale | Common Stock | 100 | $386.46 | $39K |
| Sale | Common Stock | 551 | $388.38 | $214K |
| Sale | Common Stock | 149 | $389.40 | $58K |
| Sale | Common Stock | 400 | $391.07 | $156K |
Footnotes (19)
- F1. The shares were sold pursuant to a sales plan adopted by the Reporting Person on February 27, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $357.82 to $358.66. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $358.82 to $359.75. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $359.86 to $360.75. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $361.31 to $362.24. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $362.32 to $363.31. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $363.34 to $364.32. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $364.37 to $365.34. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $366.21 to $366.58. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $367.58 to $368.53. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F11. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $368.81 to $369.68. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F12. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $373.80 to $374.67. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F13. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $375.08 to $375.12. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F14. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $378.83 to $378.88. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F15. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $380.93 to $381.28. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F16. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $382.54 to $383.13. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F17. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $388.01 to $388.87. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F18. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $389.39 to $389.44. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F19. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $391.00 to $391.18. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
Rule 10b5-1 regulatory
sales plan financial
weighted average price financial
open-market sale financial
Securities Exchange Act of 1934 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did MACOM (MTSI) report for Stephen G. Daly?
Was the MACOM (MTSI) CEO’s May 29, 2026 stock sale pre-planned?
How many transactions were included in Stephen G. Daly’s MACOM (MTSI) Form 4?
Does the MACOM (MTSI) Form 4 include derivative exercises or gifts?
AI-generated analysis. How Rhea-AI works. Not financial advice.